MedTrace Logo

Oral Duloxetine as a Premedication for Postoperative Pain Control

NCT05050656 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2021-09-20

No results posted yet for this study

Summary

The purpose of the study is to use duloxetine as premedication in Anterior cruciate ligament repair under spinal anesthesia and evaluate the effect on onset and duration of spinal anesthesia and postoperative pain control.

Conditions

  • Anesthesia

Interventions

DRUG

Duloxetine 60mg

Duloxetine is a selective SNRI prescribed in depression, anxiety, and chronic pain like diabetic neuropathy and fibromyalgia, it acts through central and peripheral pain modulation

DRUG

Placebo

placebo tablets identical to duloxetine tablets

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • tamer abdelaziz, MD · Faculty of medicine, Ain Shams University, Cairo, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2021-07-28
Completion
2021-07-29

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05050656 on ClinicalTrials.gov